India has already become the world capital of diabetes and heart diseases, and is set to acquire the same dubious distinction in other chronic diseases, too. Considering the need for long-term treatment and the higher risks these diseases pose to specific population groups, pharma companies are reworking prevalent treatment methodologies and ushering in innovations. Usha Sharma finds out
According to Anil Khanna, Partner, Wisdomsmith Advisors, “The total Indian market size for chronic diseases is over ₹ 45,000 crores and is growing significantly. The key categories are cardiac, anti-diabetic and neuro valued at ₹14369 crores, ₹10568 crores and ₹ 7072 crores, respectively. Other therapies, which have a large component of chronic medicines are respiratory (₹8579 crores), pain (₹7886 crores), gynaecological (₹5909 crores) and blood-related disease (₹1438 crores).”
Patient adherence
Most chronic diseases need a long period of treatment making patient compliance a big challenge in India. However, the industry is addressing the issues of disease duration, disease intensity, number of complications, degree of disability and management of symptoms through new drug delivery systems.
Vinod Kumar Arora, Principal Advisor, Institute of Good Manufacturing Practices India observes, “Drug delivery systems address treatment related factors, frequency of dosage, and the cost and complexity of treatment. The last decade has seen substantial accretion in industry valuation from adoption of biologics for the control of diabetes, inflammation and cancer. In the long term, we expect substantial growth in nucleic acid drugs built through approaches like microRNA, RNAi, direct mRNA, gene therapy and gene editing.”
Bu hikaye Express Pharma dergisinin January 16-31, 2018 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Express Pharma dergisinin January 16-31, 2018 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation